Sponsored by:

Nuclear Medicine: Page 425

Webster named Positron’s VP of sales, marketing
By AuntMinnie.com staff writers
Houston-based PET developer and manufacturer has appointed Wayne Webster as its vice president of sales, marketing, and service.
April 9, 2001
For doctors in the know, FDG-PET alters colorectal cancer management
By Shalmali Pal
Referring physicians who are attuned to FDG-PET's advantages are more likely to use the information for colorectal cancer treatment, according to the latest issue of the Journal of Nuclear Medicine.
April 9, 2001
2001 04 09 14 27 45 706
DuPont closes in on fate of medical imaging business
By Robert Bruce
Chemical giant DuPont is said to be close to a decision on the fate of its pharmaceutical business, which has been targeted for a sale or spin-off. But DuPont's efforts to dispose of the division have reportedly been caught between the slumping stock market and DuPont's high asking price for the business.
April 8, 2001
Sagemark to buy Premier P.E.T. Imaging, Premier Cyclotron
By AuntMinnie.com staff writers
Financial services firm Sagemark Companies may soon enter the medical imaging market.
April 4, 2001
ADAC promotes Burbach to CEO
ADAC Laboratories president and COO Gary Burbach has been promoted to CEO.
April 4, 2001
From femoral neck collars to fractures: finding the source of hip pain
By Shalmali Pal
Osteopenia is the key to separating acute hip fractures from other bone conditions that can seem remarkably similar in the emergency room. With the graying of the population, healthcare professionals will likely be seeing more of these confusing cases, according to a radiologist from the University of Rochester in New York.
April 4, 2001
2001 04 04 14 31 49 706
Theseus starts Apomate phase II trials
By AuntMinnie.com staff writers
Theseus Imaging has initiated an FDA phase II clinical study of Apomate, an imaging agent designed to detect early patient response to anti-cancer treatment.
April 2, 2001
Positron sales surge in 2000
By AuntMinnie.com staff writers
PET developer Positron reported 2000 revenues of $6.7 million, up from $1.5 million in 1999.
April 2, 2001
D-dimer assay rules out PE, DVT in emergency triage
By Shalmali Pal
The D-dimer assay has enormous potential in critical care, where it can be used to determine who should undergo further imaging. The blood test’s greatest strength lies in its high negative predictive value for deep venous thrombosis and pulmonary embolism, according to Dr. Myer Roszler from Baptist Health Systems of South Florida in Miami.
March 26, 2001
New PET radiotracer could replace FDG for detecting Alzheimer’s
By Dan Krotz
UCLA researchers say they have developed a fluorine-based PET radiotracer that detects the neural plaques and tangles that signify the onset of Alzheimer’s disease. They believes the radioactive molecule could advance imaging’s role in both the early detection of Alzheimer’s and in the development of several drugs.
March 25, 2001
Syncor buys gamma knife, radiopharmaceutical distributor
By AuntMinnie.com staff writers
Radiopharmaceutical firm Syncor International has acquired a gamma knife in Brazil and a radiopharmaceutical distributor in New Zealand.
March 21, 2001
Immunomedics appoints Sullivan CEO
Radiopharmaceutical firm Immunomedics has promoted Cynthia Sullivan to CEO.
March 20, 2001
Previous Page
Page 425 of 440
Next Page